Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review

por Hoogland, A. Marije, Kweldam, Charlotte F., van Leenders, Geert J. L. H.
Publicado 2014

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer

por Hoogland, A. Marije, Böttcher, René, Verhoef, Esther, Jenster, Guido, van Leenders, Geert J.L.H.
Publicado 2016

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer

por Böttcher, René, Hoogland, A. Marije, Dits, Natasja, Verhoef, Esther I., Kweldam, Charlotte, Waranecki, Piotr, Bangma, Chris H., van Leenders, Geert J.L.H., Jenster, Guido
Publicado 2015

Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer

por Duijvesz, Diederick, Burnum-Johnson, Kristin E., Gritsenko, Marina A., Hoogland, A. Marije, Vredenbregt-van den Berg, Mirella S., Willemsen, Rob, Luider, Theo, Paša-Tolić, Ljiljana, Jenster, Guido
Publicado 2013

Differential tissue expression of extracellular vesicle‐derived proteins in prostate cancer

por Duijvesz, Diederick, Rodriguez‐Blanco, Giovanny, Hoogland, A. Marije, Verhoef, Esther I., Dekker, Lennard J., Roobol, Monique J., van Leenders, Geert J. L. H., Luider, Theo M., Jenster, Guido
Publicado 2019

MET expression during prostate cancer progression

por Verhoef, Esther I., Kolijn, Kimberley, De Herdt, Maria J., van der Steen, Berdine, Hoogland, A. Marije, Sleddens, Hein F.B.M., Looijenga, Leendert H.J., van Leenders, Geert J.L.H.
Publicado 2016

Tissue proteomics outlines AGR2 AND LOX5 as markers for biochemical recurrence of prostate cancer

por Rodríguez-Blanco, Giovanny, Zeneyedpour, Lona, Duijvesz, Diederick, Hoogland, A. Marije, Verhoef, Esther I., Kweldam, Charlotte F., Burgers, Peter C., Smitt, Peter Sillevis, Bangma, Chris H., Jenster, Guido, van Leenders, Geert J.L.H., Dekker, Lennard J.M., Luider, Theo M.
Publicado 2018